• Oxford Nanopore's Newly Named CEO Brings Diagnostics Expertise

    Bio-IT World | Oxford Nanopore Technologies named a new CEO this morning, choosing an executive with extensive diagnostics experience. Francis Van Parys, currently CEO of Radiometer, will join Oxford Nanopore and the Board as an Executive Director on March 2, 2026.

    Dec 8, 2025

  • National University of Singapore Launches First Global Medical AI Foundation Model

    Bio-IT World | Since artificial intelligence (AI) made its way into the medical field, foundation models—machine learning systems that are trained on broad data and adaptable to a wide range of downstream tasks—have become a focus. These foundation models are used to perform various medical tasks with minimal amounts of data. Of course, this means that these models require robust training, which poses a challenge for researchers.

    Dec 4, 2025

  • How Next-Gen Biotechnology Is Transforming Genetic Risk Prediction

    Bio-IT World | As genetic testing becomes a routine part of modern medicine, researchers are grappling with an unintended consequence: a flood of never-before-seen genetic variants whose clinical significance is unknown. These variants of uncertain significance (VUS), now number in the tens of thousands, outpace the capacity of traditional scientific methods to determine whether they contribute to disease.

    Dec 3, 2025

  • Psychedelics and Patient Selection Tools Propelling Precision Psychiatry

    Bio-IT World | How depression gets treated in the next decade is poised for significant change thanks to encouraging developments in the use of psychedelics and dissociative compounds like ketamine to alleviate symptoms of the mood disorder. Scientific interest in psychedelic-based therapies has skyrocketed in recent years, driven by promising clinical trial outcomes, a flood of financial investment, and the urgent need for new treatments to counter a growing mental health crisis

    Dec 2, 2025

  • Follow the Money: Enveloped Delivery Vehicle Technology, Oral Medication for Inflammatory, Neurological Diseases, More

    Bio-IT World | Azalea Therapeutics will advance their Enveloped Delivery Vehicle (EDV) technology; Gate Biosciences will advance inflammatory and neurological disease treatments through the convenience of a pill; and more.

    Nov 25, 2025

  • Eli Lilly to Open Lab in Philadelphia, QIAGEN to Acquire Parse Biosciences, Novartis Expands to North Carolina

    Bio-IT World | Eli Lilly plans to open a new lab in Philadelphia; QIAGEN enters into a definitive agreement to fully acquire Parse Biosciences; Novartis announced plans to expand a flagship hub in North Carolina; and more.

    Nov 24, 2025

  • Ginkgo Datapoints Launches Virtual Cell Pharmacology Initiative

    Bio-IT World | Ginkgo Datapoints has launched V-Ref293, a novel engineered cell line designated specifically as the reference standard for virtual cell research. Along with the cell line, the group is launching the Virtual Cell Pharmacology Initiative (VCPI), the first project under The Virtual Cell bio-AI community platform from Ginkgo Datapoints.

    Nov 21, 2025